TY - JOUR
T1 - The Emerging Facets of Non-Cancerous Warburg Effect
AU - Abdel-Haleem, Alyaa M.
AU - Lewis, Nathan E.
AU - Jamshidi, Neema
AU - Mineta, Katsuhiko
AU - Gao, Xin
AU - Gojobori, Takashi
N1 - KAUST Repository Item: Exported on 2020-10-01
Acknowledged KAUST grant number(s): URF/1/1976-03
Acknowledgements: AMA, XG, KM, and TG acknowledge funding from King Abdullah University of Science and Technology (KAUST) and the Office of Sponsored Research (OSR) under Award No. URF/1/1976-03. NL acknowledges generous support from the Novo Nordisk Foundation grant NNF10CC1016517 and NIH (R35-GM119850 and R01 AI090141).
PY - 2017/10/23
Y1 - 2017/10/23
N2 - The Warburg effect (WE), or aerobic glycolysis, is commonly recognized as a hallmark of cancer and has been extensively studied for potential anti-cancer therapeutics development. Beyond cancer, the WE plays an important role in many other cell types involved in immunity, angiogenesis, pluripotency, and infection by pathogens (e.g., malaria). Here, we review the WE in non-cancerous context as a
AB - The Warburg effect (WE), or aerobic glycolysis, is commonly recognized as a hallmark of cancer and has been extensively studied for potential anti-cancer therapeutics development. Beyond cancer, the WE plays an important role in many other cell types involved in immunity, angiogenesis, pluripotency, and infection by pathogens (e.g., malaria). Here, we review the WE in non-cancerous context as a
UR - http://hdl.handle.net/10754/626124
UR - https://www.frontiersin.org/articles/10.3389/fendo.2017.00279/full
UR - http://www.scopus.com/inward/record.url?scp=85032183362&partnerID=8YFLogxK
U2 - 10.3389/fendo.2017.00279
DO - 10.3389/fendo.2017.00279
M3 - Article
C2 - 29109698
SN - 1664-2392
VL - 8
JO - Frontiers in Endocrinology
JF - Frontiers in Endocrinology
IS - OCT
ER -
